These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 7457356)
21. APHA's occupational health section. Dolan MB Occup Health Nurs; 1973 Jun; 21(6):20 passim. PubMed ID: 4735900 [No Abstract] [Full Text] [Related]
22. The need for policies on employee substance abuse. Stickler KB; Nelson MD Healthspan; 1986; 3(8):3-7. PubMed ID: 10317792 [No Abstract] [Full Text] [Related]
23. APHA's involvement in international health. Pearson CE Am J Public Health; 1999 Jul; 89(7):1125-6. PubMed ID: 10394334 [No Abstract] [Full Text] [Related]
24. Just say 'No'. Policies, procedures, and legal considerations for maintaining a drug-free work-place environment. Slogoff RJ Provider; 1998 Jan; 24(1):49-50. PubMed ID: 10175136 [No Abstract] [Full Text] [Related]
25. Prescription drug abuse: FDA and SAMHSA join forces. Meadows M FDA Consum; 2003; 37(2):36. PubMed ID: 12715769 [No Abstract] [Full Text] [Related]
26. Prescribing practices and drug abuse--perspective of the American Society of Addiction Medicine. Geller A NIDA Res Monogr; 1993; 131():242-5. PubMed ID: 8413537 [No Abstract] [Full Text] [Related]
27. Substance abuse in the workplace: epidemiology, effects, and industry response. Bush DM; Autry JH Occup Med; 2002; 17(1):13-25, iii. PubMed ID: 11726333 [TBL] [Abstract][Full Text] [Related]
28. Financing of substance abuse treatment for children and adolescents. Committee on Child Health Financing and Committee on Substance Abuse, American Academy of Pediatrics. Pediatrics; 1995 Feb; 95(2):308-10. PubMed ID: 7838656 [No Abstract] [Full Text] [Related]
29. Prescription drug abuse by U.S. teenagers. Krafka TL S D Med; 2007 Sep; 60(9):361, 363. PubMed ID: 17987869 [No Abstract] [Full Text] [Related]
30. Social and legal factors related to drug abuse in the United States and Japan. Greberman SB; Wada K Public Health Rep; 1994; 109(6):731-7. PubMed ID: 7800780 [TBL] [Abstract][Full Text] [Related]
31. Perinatal substance abuse and human subjects research: are privacy protections adequate? Marshall MF; Menikoff J; Paltrow LM Ment Retard Dev Disabil Res Rev; 2003; 9(1):54-9. PubMed ID: 12587139 [TBL] [Abstract][Full Text] [Related]
32. The effects of drug abuse on pregnancy. Kuczkowski KM Curr Opin Obstet Gynecol; 2007 Dec; 19(6):578-85. PubMed ID: 18007137 [TBL] [Abstract][Full Text] [Related]
33. Workshop challenges veterinary community to address substance abuse. Raef TA J Am Vet Med Assoc; 1995 Aug; 207(3):290-1. PubMed ID: 7628925 [No Abstract] [Full Text] [Related]
34. Substance abuse and dependence in physicians: an overview of the effects of alcohol and drug abuse. Bohigian GM; Croughan JL; Sanders K Mo Med; 1994 May; 91(5):233-9. PubMed ID: 8041352 [TBL] [Abstract][Full Text] [Related]
35. Controlled prescription drug abuse at epidemic level. National Center on Addiction and Substance Abuse J Pain Palliat Care Pharmacother; 2006; 20(2):61-4. PubMed ID: 16702139 [TBL] [Abstract][Full Text] [Related]
36. Alcohol, Drug Abuse, and Mental Health Services block grant state waiver guidelines; construction or rehabilitation of substance abuse facilities--ADAMHA. Notice. Fed Regist; 1989 Jun; 54(105):23699-700. PubMed ID: 10318231 [No Abstract] [Full Text] [Related]
37. Drug testing in the work place: a primer for employers. Hartstein BA Employee Relat Law J; 1987; 12(4):577-608. PubMed ID: 10317874 [TBL] [Abstract][Full Text] [Related]
38. Involving the pharmaceutical and biotech communities in medication development for substance abuse. Gorodetzky CW; Grudzinskas C Pharmacol Ther; 2005 Oct; 108(1):109-18. PubMed ID: 16038981 [TBL] [Abstract][Full Text] [Related]
39. Substance abuse, treatment, and the courts. Alcohol and drug abuse contributing factor in 80% of U.S. crimes. J Psychosoc Nurs Ment Health Serv; 1997 Jul; 35(7):8-9. PubMed ID: 9243416 [No Abstract] [Full Text] [Related]
40. The acquisition of drug abuse information for the National Clearinghouse for Drug Abuse Information. Lachter SB Drug Inf J; 1975; 9(2-3):195-8. PubMed ID: 10316630 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]